TRVI

Trevi Therapeutics Inc.

Price

$18.81

return (12m)

156.97%

p/e

-56.34

p/bv

8.96

DIVIDEND YIELD

0.00%

TRVI price

Trevi Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment TRVI

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

6.69%

3 months

32.84%

1 year

156.97%

2 years

533.33%

5 years

1,046.95%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals TRVI

Valuation

P/E

-56.34

Sector -2.19

Industry 1.21

P/BV

8.96

Sector 2.22

Industry 2.11

P/Revenue (PSR)

Sector 2.01

Industry 0.78

EV/EBITDA

-125.02

Sector -17.81

Industry -25.30

EV/EBIT

-124.84

Sector -26.72

Industry -18.04

P/EBITDA

-51.94

Sector 0.36

Industry 0.18

P/EBIT

-51.82

Sector -3.34

Industry 1.26

P/Total Assets

8.71

Sector 1.23

Industry 0.86

P/Net Current Assets

9.09

Sector -27.35

Industry -12.37

P/Working Capital

9.08

Sector -4.54

Industry -49.48

EPS

-0.33

Sector -0.87

Industry -0.55

BVPS

2.05

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

0.00%

Sector 43.36%

Industry 31.53%

EBITDA Margin

Sector -323.65%

Industry -73.39%

EBIT Margin

Sector -194.57%

Industry -11.94%

Operating Margin

0.00%

Sector -24.37%

Industry -9.87%

Net Profit Margins

0.00%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.00

Sector 0.12

Industry 0.22

Profitability

ROE

-15.90%

Sector -33.82%

Industry -37.56%

ROA

-15.46%

Sector -29.63%

Industry -17.56%

ROIC

-1,330.15%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

37.27

Sector 1.84

Industry 1.14

Net Debt / EBITDA

15.57

Sector -1.47

Industry -31.86

Net Debt / EBIT

15.55

Sector -1.32

Industry 2.06

Net Debt / Equity

-0.99

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.00

Sector 0.14

Industry 0.51

Equity/Assets

0.97

Sector 0.42

Industry 0.25

Liabilities/Assets

0.03

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

8.54%

Sector -

Industry -

Fundamentals TRVI

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
TRVI Trevi Therapeutics Inc.	$18.81	152.48%	0.00%	-56.34	8.96	-15.90%	0.00%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TRVI Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Trevi Therapeutics

Trevi Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

15 years

Founded: 2011

2019

Time since IPO - 7 years

22

Employees

Trevi Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.88 billion, with shareholders equity totaling $321.51 million.

The company employs approximately 22 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Trevi Therapeutics Inc. reported $- in revenue, generating net income of $-51.11 million.

Key financial metrics include a P/E ratio of -56.34, a price-to-book (P/B) ratio of 8.96, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TRVI.

Market cap

$2.88 billion

Net worth

$321.51 million

$321,510,000.00

Assets

$330.52 million

$330,520,000.00

Total Shares Outstanding

157.00 million

157,000,000

Average Daily Trading Volume

$2.33 million

$2,327,906.00

Sector

Health

Industry

Pharmaceutical Products

TRVI

TRVI revenue and profits

Financial Results TRVI

DRAG THE FRAME TO SEE MORE DATA

TRVI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87